Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy

BACKGROUND: Predicting treatment benefit and/or outcome before any therapeutic intervention has taken place would be clinically very useful. Herein, we evaluate the ability of the intrinsic subtypes and the risk of relapse score at diagnosis to predict survival and response following neoadjuvant che...

Descripción completa

Detalles Bibliográficos
Autores principales: Prat, Aleix, Fan, Cheng, Fernández, Aranzazu, Hoadley, Katherine A., Martinello, Rossella, Vidal, Maria, Viladot, Margarita, Pineda, Estela, Arance, Ana, Muñoz, Montserrat, Paré, Laia, Cheang, Maggie C. U., Adamo, Barbara, Perou, Charles M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683815/
https://www.ncbi.nlm.nih.gov/pubmed/26684470
http://dx.doi.org/10.1186/s12916-015-0540-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683815/
https://www.ncbi.nlm.nih.gov/pubmed/26684470
http://dx.doi.org/10.1186/s12916-015-0540-z

Ejemplares similares